Investing Profile

Peter Svennilson

InvestorVCFounder
Managing Partner & Founder at The Column Group
thecolumngroup.com/member/pet...San Francisco, California
Photo of Peter Svennilson, Managing Partner at The Column Group
Your Intro Paths to Peter Svennilson

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Peter Svennilson on

cb
Current Investing Position
The Column Group Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
16
Current Fund Size
$600M

Peter Svennilson is on these Sector & Stage Rankings

Pharmaceuticals (Series B)Pharmaceuticals (Series A)Pharmaceuticals (Seed)Consumer Health (Series B)Digital Health (Series B)BioTech (Series B)Pharmaceuticals (Series B)Health & Hospital Services (Series B)Consumer Health (Series B)Pharmaceuticals (Series A)Health IT (Series B)Consumer Health (Series A)Pharmaceuticals (Seed)Consumer Health (Seed)Digital Health (Series A)Digital Health (Seed)BioTech (Series A)Health & Hospital Services (Series A)Health & Hospital Services (Seed)BioTech (Seed)Consumer Health (Series A)BioTech (Series B)Health IT (Seed)Health IT (Series A)Digital Health (Series B)Health IT (Series B)Digital Health (Series A)Consumer Health (Seed)Health & Hospital Services (Series B)BioTech (Seed)BioTech (Series A)Digital Health (Seed)Health IT (Series A)Health IT (Seed)Health & Hospital Services (Seed)Health & Hospital Services (Series A)San Francisco Bay Area

Peter Svennilson's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Remix Therapeutics
Series UnknownJan 2024$60M
$210M
Co-investors: Michael Rome (Foresite Capital), Leon Chen (The Column Group), Kevin Bitterman (Atlas Venture), Kristina Burow (ARCH Venture Partners)
Carmot Therapeutics
Series EMay 2023$150M
Series DJul 2022$160M
Series CSep 2020$47M
Series BJan 2018$15M
Series UnknownJul 2012$500K
Series AApr 2010$2M
$370M
Co-investors: Derek DiRocco (RA Capital), Zachary Hargreaves
Circle Pharma
Series BMar 2020$45M
$45M
Co-investors: Thilo Schroeder (Nextech Invest), Eric Anschutz
Gritstone bio
Series BSep 2017$93M
Series AOct 2015$100M
$320M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Tom Woiwode (Versant Ventures)
NGM Biopharmaceuticals
Series DMar 2015$58M
Series BMar 2010$55M
Series ADec 2009$27M
$140M
Co-investors: David Goeddel (The Column Group)
Aragon Pharmaceuticals
Series DOct 2012$50M
Series BApr 2010$22M
Series AMay 2009$8M
$80M
Co-investors: Carl Gordon (OrbiMed), Brett Zbar (Foresite Capital), Josh Bilenker (Aisling Capital)